MedTrace Logo

Cervical Interbody Fusion Device Patient Registry

NCT05114356 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2024-07-03

No results posted yet for this study

Summary

The registry has been designed as a prospective, observational program for patients undergoing anterior cervical discectomy and fusion (ACDF) procedures treated with TIDAL cervical interbody fusion device. The ultimate goal of the study is to aid in the development of treatment pathways and improved patient care. All patients who agree to participate in the registry will sign an informed consent form and subsequently be treated by their surgeon with the device in either an inpatient or outpatient facility.

Conditions

  • Degenerative Disc Disease

Interventions

DEVICE

TIDAL Cervical Interbody Fusion implant

Cervical interbody fusion device

Sponsors & Collaborators

  • Restor3D

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-08
Primary Completion
2024-05-22
Completion
2024-05-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05114356 on ClinicalTrials.gov